Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) reported earnings this Morning, coming in at ($0.24) per share, missing Wall Street’s estimates of ($0.23) per Share. Revenue for the quarter came in at $34.20 million beating analyst estimates of $34.16 million Recent Insider Trading for Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL)
- On 12/15/2017 Craig R Stapleton, Director, bought 140,000 with an average share price of $8.67 per share and the total transaction amounting to $1,213,800.00.
- On 12/7/2017 Michael S. Anderson, CEO, bought 5,000 with an average share price of $8.86 per share and the total transaction amounting to $44,300.00.
- On 11/27/2017 Craig R Stapleton, Director, sold 254,265 with an average share price of $9.35 per share and the total transaction amounting to $2,377,377.75.
- On 9/21/2017 Peter J Thornton, Director, bought 5,155 with an average share price of $9.74 per share and the total transaction amounting to $50,209.70.
- On 9/14/2017 Sandra L. Hatten, Insider, bought 2,100 with an average share price of $9.36 per share and the total transaction amounting to $19,656.00.
- On 9/13/2017 Phillandas T. Thompson, Insider, bought 5,000 with an average share price of $9.36 per share and the total transaction amounting to $46,800.00.
Recent Trading for Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) Shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share closed the previous trading session at 8.12 down -0.07 0.85% with shares trading hands.